Cushing's Disease
Also known as: Cushing Disease / Pituitary-dependent Cushing's disease / Pituitary-dependent Cushing's disease (disorder) / Pituitary ACTH Hypersecretion / Pituitary-dependent Cushing's syndrome
Drug | Drug Name | Drug Description |
---|---|---|
DB11837 | Osilodrostat | An oral inhibitor of cortisol synthesis used to treat Cushing's disease by normalizing hypercortisolism. |
DB06663 | Pasireotide | A somatostatin analog used in the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery is not appropriate. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00307 | Bexarotene | 1 / 2 | Unknown Status | 1 |
DB00248 | Cabergoline | 2 | Terminated | 1 |
DB11891 | Fimepinostat | 2 | Not Yet Recruiting | 1 |
DB00317 | Gefitinib | 2 | Unknown Status | 1 |
DB11837 | Osilodrostat | 2 | Completed | 1 |
DB11837 | Osilodrostat | 2 | Recruiting | 1 |
DB06663 | Pasireotide | 2 | Completed | 1 |
DB06663 | Pasireotide | 2 | Terminated | 1 |
DB00412 | Rosiglitazone | 2 | Terminated | 1 |
DB06195 | Seliciclib | 2 | Recruiting | 1 |
DB06195 | Seliciclib | 2 | Terminated | 1 |
DB02546 | Vorinostat | 2 | Recruiting | 1 |
DB00248 | Cabergoline | 3 | Completed | 1 |
DB05667 | Levoketoconazole | 3 | Completed | 1 |
DB00834 | Mifepristone | 3 | Completed | 1 |
DB00834 | Mifepristone | 3 | Withdrawn | 1 |
DB11837 | Osilodrostat | 3 | Completed | 2 |
DB06663 | Pasireotide | 3 | Completed | 3 |
DB00248 | Cabergoline | 4 | Active Not Recruiting | 1 |
DB00030 | Insulin human | 4 | Completed | 1 |
DB06655 | Liraglutide | 4 | Completed | 1 |
DB00331 | Metformin | 4 | Completed | 1 |
DB06663 | Pasireotide | 4 | Active Not Recruiting | 1 |
DB06663 | Pasireotide | 4 | Completed | 2 |
DB01261 | Sitagliptin | 4 | Completed | 1 |
DB09067 | Corticorelin ovine triflutate | Not Available | Not Yet Recruiting | 1 |
DB06663 | Pasireotide | Not Available | Recruiting | 1 |
DB06228 | Rivaroxaban | Not Available | Recruiting | 1 |